Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Atsuko Hirabae"'
Publikováno v:
Genes and Environment, Vol 45, Iss 1, Pp 1-13 (2023)
Abstract We investigated the chemopreventive effects of beer, nonalcoholic beers (NABs), and beer-components (glycine betaine (GB)) on NNK-induced lung tumorigenesis in A/J mice, and the possible mechanisms underlying the antitumorigenic effects of b
Externí odkaz:
https://doaj.org/article/343c1dbabdcf404d8706a8d50bd124b7
Autor:
Johannes Brägelmann, Carina Lorenz, Sven Borchmann, Kazuya Nishii, Julia Wegner, Lydia Meder, Jenny Ostendorp, David F. Ast, Alena Heimsoeth, Takamasa Nakasuka, Atsuko Hirabae, Sachi Okawa, Marcel A. Dammert, Dennis Plenker, Sebastian Klein, Philipp Lohneis, Jianing Gu, Laura K. Godfrey, Jan Forster, Marija Trajkovic-Arsic, Thomas Zillinger, Mareike Haarmann, Alexander Quaas, Stefanie Lennartz, Marcel Schmiel, Joshua D’Rozario, Emily S. Thomas, Henry Li, Clemens A. Schmitt, Julie George, Roman K. Thomas, Silvia von Karstedt, Gunther Hartmann, Reinhard Büttner, Roland T. Ullrich, Jens T. Siveke, Kadoaki Ohashi, Martin Schlee, Martin L. Sos
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Kinase inhibitors are widely used to treat cancer, however patients frequently develop resistance. Here, the authors investigate adaption mechanisms during drug persistence and show that stimulation of the innate immunity sensor RIG-I enhances cancer
Externí odkaz:
https://doaj.org/article/9def69d01bbd4809814653393e15ac1f
Autor:
Kazuya Nishii, Kadoaki Ohashi, Shuta Tomida, Takamasa Nakasuka, Atsuko Hirabae, Sachi Okawa, Jun Nishimura, Hisao Higo, Hiromi Watanabe, Hirohisa Kano, Chihiro Ando, Go Makimoto, Kiichiro Ninomiya, Yuka Kato, Toshio Kubo, Eiki Ichihara, Katsuyuki Hotta, Masahiro Tabata, Shinichi Toyooka, Heiichiro Udono, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Cancer Immunology Research. 10:1111-1126
Epidermal growth factor receptor (EGFR) is the most frequently mutated driver oncogene in nonsmoking-related, non–small cell lung cancer (NSCLC). EGFR-mutant NSCLC has a noninflamed tumor microenvironment (TME), with low infiltration by CD8+ T cell
Autor:
Katsuyuki Kiura, Yoshinobu Maeda, Heiichiro Udono, Shinichi Toyooka, Masahiro Tabata, Katsuyuki Hotta, Eiki Ichihara, Toshio Kubo, Yuka Kato, Kiichiro Ninomiya, Go Makimoto, Chihiro Ando, Hirohisa Kano, Hiromi Watanabe, Hisao Higo, Jun Nishimura, Sachi Okawa, Atsuko Hirabae, Takamasa Nakasuka, Shuta Tomida, Kadoaki Ohashi, Kazuya Nishii
Supplementary Data from CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::610e013c0c04a60d25f48a18123bd4da
https://doi.org/10.1158/2326-6066.22545332
https://doi.org/10.1158/2326-6066.22545332
Autor:
Katsuyuki Kiura, Yoshinobu Maeda, Heiichiro Udono, Shinichi Toyooka, Masahiro Tabata, Katsuyuki Hotta, Eiki Ichihara, Toshio Kubo, Yuka Kato, Kiichiro Ninomiya, Go Makimoto, Chihiro Ando, Hirohisa Kano, Hiromi Watanabe, Hisao Higo, Jun Nishimura, Sachi Okawa, Atsuko Hirabae, Takamasa Nakasuka, Shuta Tomida, Kadoaki Ohashi, Kazuya Nishii
Supplementary Figure from CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2334d452502440a0d62f9426fd9125e4
https://doi.org/10.1158/2326-6066.22545329.v1
https://doi.org/10.1158/2326-6066.22545329.v1
Autor:
Katsuyuki Kiura, Yoshinobu Maeda, Heiichiro Udono, Shinichi Toyooka, Masahiro Tabata, Katsuyuki Hotta, Eiki Ichihara, Toshio Kubo, Yuka Kato, Kiichiro Ninomiya, Go Makimoto, Chihiro Ando, Hirohisa Kano, Hiromi Watanabe, Hisao Higo, Jun Nishimura, Sachi Okawa, Atsuko Hirabae, Takamasa Nakasuka, Shuta Tomida, Kadoaki Ohashi, Kazuya Nishii
Epidermal growth factor receptor (EGFR) is the most frequently mutated driver oncogene in nonsmoking-related, non–small cell lung cancer (NSCLC). EGFR-mutant NSCLC has a noninflamed tumor microenvironment (TME), with low infiltration by CD8+ T cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2545f28bebbe52ae229d98e350c440b3
https://doi.org/10.1158/2326-6066.c.6550913
https://doi.org/10.1158/2326-6066.c.6550913
Autor:
Toshio Kubo, Atsuko Hirabae, Yoshitaka Iwamoto, Yoshinobu Maeda, Masahiro Tabata, Katsuyuki Kiura, Akihiko Taniguchi, Kenji Takada, Ryota Sunami, Sachi Okawa, Shunichi Kawamura
Publikováno v:
Int Cancer Conf J
A 62-year-old woman with edema and color changes in her fingers underwent computed tomography (CT); slight interstitial changes were detected in the lungs with multiple tumors in the anterior and hilar region of the liver. Based on the blood test fin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa647a44c447a0f580c2fc2d1261632
https://europepmc.org/articles/PMC8206247/
https://europepmc.org/articles/PMC8206247/
Autor:
Toshio Kubo, Hiroe Kayatani, Atsuko Hirabae, Hirohisa Kano, Hisao Higo, Eiki Ichihara, Yoshinobu Maeda, Naofumi Hara, Kiichiro Ninomiya, Sachi Okawa, Hiromi Watanabe, Masahiro Tabata, Go Makimoto, Kazuya Nishii, Kammei Rai, Kadoaki Ohashi, Takashi Ninomiya, Yuka Kato, Chihiro Ando, Takamasa Nakasuka, Katsuyuki Kiura, Katsuyuki Hotta
Publikováno v:
Cancer Science
Molecular agents targeting the epidermal growth factor receptor (EGFR)‐, anaplastic lymphoma kinase (ALK)‐ or c‐ros oncogene 1 (ROS1) alterations have revolutionized the treatment of oncogene‐driven non‐small‐cell lung cancer (NSCLC). How
Autor:
Chihiro Ando, Yoshinobu Maeda, Eiki Ichihara, Katsuyuki Kiura, Hirohisa Kano, Yoshitaka Iwamoto, Takamasa Nakasuka, Atsuko Hirabae
Atypical tumor responses such as pseudo-progression or hyper-progression sometimes occur during immune check point inhibitor therapy. Distinct from both responses, we experienced a case of non-small cell lung cancer (NSCLC) with a pseudo-relapse, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82971f477289fef5c0b4cefe4019f80b
https://europepmc.org/articles/PMC6899131/
https://europepmc.org/articles/PMC6899131/
Publikováno v:
Haigan. 58:127-131